Wockhardt Limited (BOM:532300)

India flag India · Delayed Price · Currency is INR
2,151.85
+121.15 (5.97%)
At close: Jun 1, 2026
Market Cap330.09B +65.9%
Revenue (ttm)33.73B +11.1%
Net Income2.13B
EPS13.10
Shares Out n/a
PE Ratio154.97
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume490,643
Open2,377.95
Previous Close2,030.70
Day's Range2,127.25 - 2,420.00
52-Week Range1,086.80 - 2,420.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 4, 2026

About Wockhardt

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an anti... [Read more]

Industry Pharmaceutical Preparations
Founded 1967
Employees 2,296
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532300
Full Company Profile

Financial Performance

Financial Statements

News

Pharma Stocks Today, June 1: Wockhardt surges 12%, Natco Pharma crashes 6%, Glenmark Pharma down 3.63%

Pharmaceutical stocks traded mixed on June 1, 2026, during the early morning session. While a few stocks like Wockhardt and Sudeep Pharma posted strong gains, several others, including Natco Pharma…

10 hours ago - Business Upturn

Wockhardt shares jump over 12% after US FDA approves Novel Antibiotic ZAYNICH

Wockhardt Ltd. shares jumped more than 12% in intraday trade after the company announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepime and zidebactam), a novel…

10 hours ago - Business Upturn

Wockhardt receives U.S. FDA approval for ZAYNICH, a novel antibiotic for cUTI

Wockhardt has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for ZAYNICH™ (cefepime and zidebactam), a novel intravenous antibiotic designed to treat adult pa...

2 days ago - Business Upturn

Top gainers today: netweb at ₹4,670.70 up 14.70%, wockhardt at ₹2,031.40 up 14.70%, thermax at ₹4,982.70 up 8.54%

In a session marked by overall declines in the Indian stock market, with the Sensex dropping by 1.44% to 74,775.74 and the Nifty 50 falling by 1.50% to 23,547.75, a…

3 days ago - Business Upturn

Top gainers in morning trade: netweb at ₹4,447 up 9.21%, wockhardt at ₹1,919.40 up 8.38%, thermax at ₹4,959.30 up 8.03%

The Indian stock market displayed a mixed performance in the morning session, with the Sensex inching up by 0.10% to 75,944.41, while the Nifty 50 saw a slight decline of…

3 days ago - Business Upturn

Pharma sector stocks today, May 29: Wockhardt jumps 7.40%, Indoco Remedies rises 3.46%, Sudeep Pharma up 3.45%

The pharmaceutical stocks traded mixed on May 29, 2026, during the morning session. While some stocks like Wockhardt, Indoco Remedies, and Sudeep Pharma posted strong gains, a few others saw…

3 days ago - Business Upturn

Wockhardt receives marketing authorisation for breakthrough antibiotic Zaynich in India

Wockhardt Ltd. has announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for its innovative antibiotic, Zaynich® (Zidebactam/Cefepime), in...

4 days ago - Business Upturn

Pharma sector stocks today, May 27: Panacea Biotech rises 2.83%, Wockhardt up 2.71%, Aurobindo Pharma down 0.17%

Pharmaceutical stocks traded mixed during the morning session on May 27, 2026. While some stocks posted decent gains, a few names saw mild selling pressure. The BSE Healthcare index rose…

5 days ago - Business Upturn

Pharma sector stocks today, May 26: Wockhardt rises 3.91%, Sudeep Pharma up 2.10%, Aarti Drugs gains 2.35%

Pharmaceutical stocks showed a mixed performance on May 26, 2026, during the morning session. While several stocks posted gains, a few names traded lower. The BSE Healthcare index was down…

6 days ago - Business Upturn

Pharma Stocks Today, May 13: Wockhardt rises 1.97%, Orchid Pharma falls 1.79%, Biocon gains 1.38%

Indian pharmaceutical stocks showed a mixed trend on May 13 2026 during the early morning trading session. The BSE Healthcare index remained nearly flat, rising marginally by 0.04% to 46,087.93.…

19 days ago - Business Upturn

Top losers today: godrej consumer products at ₹1,036.60 down 5.26%, wockhardt at ₹1,637.50 falls 4.62%, brigade enterprises at ₹773.15 slips 4.43%

The Indian stock market experienced a slight downturn today, with the SENSEX closing at 77,844.52, down by 0.15%, and the NIFTY 50 at 24,326.65, a marginal decrease of 0.02%. Among…

25 days ago - Business Upturn

Top losers in morning trade: godrej consumer products at ₹1,043.40 down 4.63%, KPIT technologies at ₹715.00 falls 4.49%, wockhardt at ₹1,643.50 slips 4.28%

In the morning session of the Indian stock market, the SENSEX and NIFTY 50 indices showed slight declines, with the SENSEX at 77,842.60, down 0.15%, and the NIFTY 50 at…

25 days ago - Business Upturn

Pharma sector stocks today, May 7: Wockhardt falls 4%, Panacea Biotec jumps 2.16%, Biocon up 1%

Pharma sector performance remained largely stable in early trading on May 7, 2026. The NIFTY PHARMA Index stood at 24,108.9, showing no change (down 0.0%). The broader S&P BSE HEALTHCARE…

25 days ago - Business Upturn

Top gainers in morning trade: wockhardt at ₹1,731.30 up 12.64%, tejas networks at ₹477.80 up 12.27%, coforge at ₹1,272.50 up 8.87%

The Indian stock market opened on a positive note today, buoyed by favourable global cues and a decline in global crude prices. The Nifty 50 surged past the 24,100 mark,…

26 days ago - Business Upturn

Pharma sector stocks rises today, May 6: Wockhardt jumps 7.16%, Ajanta Pharma surges 3.56%, Lupin up 1.60%

Indian pharmaceutical stocks traded higher in the early session on May 6, 2026. The Nifty Pharma index stood at 23,732.2, up 0.7%. The broader market also showed modest gains, with…

26 days ago - Business Upturn

Top gainers in morning trade: wockhardt at ₹1,567.70 up 10.01%, quess corp at ₹229.50 up 8.44%, Tata technologies at ₹636.95 up 7.77%

Indian equity markets opened to a challenging session as geopolitical tensions weighed heavily on investor sentiment. Despite the broader market downturn, with the Sensex falling over 300 points and t...

27 days ago - Business Upturn

Pharma sector stocks today, May 5: Wockhardt surges over 8%, Strides Pharma rises 1.81%, Natco Pharma up 1.36%

India's pharmaceutical sector showed a mixed opening on May 5, 2026, with the S&P BSE Healthcare index trading at 45,222.25, down 0.10% in early trade. While most pharma counters were…

27 days ago - Business Upturn

Why are Wockhardt share price up over 10% today? Explained

Wockhardt shares rallied more than 10% in early trade on May 5, 2026, after the pharmaceutical company reported a sharp turnaround in its March quarter (Q4FY26) earnings. The company posted…

27 days ago - Business Upturn

Wockhardt reports Rs 238 crore profit before tax for FY26

Wockhardt Limited, the pharmaceutical and biotechnology major, has reported a significant turnaround in its financial performance for the fiscal year 2025-26. The company achieved a profit before tax ...

4 weeks ago - Business Upturn

Wockhardt Quarterly report: Q4 2026

Wockhardt has published its Q4 2026 quarterly earnings report on May 4, 2026.

4 weeks ago - Filings

Pharma sector stocks today, April 21: Wockhardt surge 2.08%, Natco Pharma down 1.86%, Ajanta Pharma up 1.10%

The Indian pharma sector opened on a mixed note on April 21, 2026 (as of 9:43 AM). The S&P BSE Healthcare Index stood at 43,475.50, up 0.23%, while the NIFTY…

5 weeks ago - Business Upturn

Pharma sector stocks today, March 30: Suven Life surge 7.88%, Wockhardt up 3.27%, Gland Pharma falls 2.36%

As of approximately 9:33 AM IST on March 30, 2026 (BSE prices) and 9:34 AM IST (NSE prices), most pharma sector stocks on the BSE and NSE were trading in…

2 months ago - Business Upturn

Wockhardt shares surge 3% after positive CDSCO panel nod for new antibiotic Zaynich

Shares of Wockhardt gained around 3% after the company announced that its novel antibiotic, Zaynich® (Zidebactam/Cefepime), received a favourable recommendation from the Subject Expert Committee (SEC)...

2 months ago - Business Upturn

Pharma sector stocks today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32%

Several pharmaceutical stocks traded higher in early morning sessions on the BSE and NSE. The S&P BSE Healthcare Index stood at 42,461.1, reflecting a gain of 1.4% for the day.…

2 months ago - Business Upturn

Pharma sector stocks rally sharply today, March 25: Wockhardt surge 7.40%, Senores Pharma up 5.95%, Natco Pharma jumps 3.32%

Several pharmaceutical stocks traded higher in early morning sessions on the BSE and NSE. The S&P BSE Healthcare Index stood at 42,461.1, reflecting a gain of 1.4% for the day.…

2 months ago - Business Upturn